Apellis Pharmaceuticals Inc (NASDAQ: APLS) kicked off on Tuesday, up 5.62% from the previous trading day, before settling in for the closing price of $17.62. Over the past 52 weeks, APLS has traded in a range of $16.10-$42.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 20.08% over the past five years. While this was happening, its average annual earnings per share was recorded -21.78%. With a float of $103.37 million, this company’s outstanding shares have now reached $125.66 million.
Let’s look at the performance matrix of the company that is accounted for 710 employees. In terms of profitability, gross margin is 82.94%, operating margin of -24.0%, and the pretax margin is -28.66%.
Apellis Pharmaceuticals Inc (APLS) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Apellis Pharmaceuticals Inc is 17.75%, while institutional ownership is 100.11%. The most recent insider transaction that took place on Jun 16 ’25, was worth 93,850. In this transaction General Counsel of this company sold 5,000 shares at a rate of $18.77, taking the stock ownership to the 133,730 shares. Before that another transaction happened on Jun 16 ’25, when Company’s Officer proposed sale 5,000 for $18.77, making the entire transaction worth $93,850.
Apellis Pharmaceuticals Inc (APLS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -21.78% per share during the next fiscal year.
Apellis Pharmaceuticals Inc (NASDAQ: APLS) Trading Performance Indicators
Take a look at Apellis Pharmaceuticals Inc’s (APLS) current performance indicators. Last quarter, stock had a quick ratio of 3.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Apellis Pharmaceuticals Inc (APLS)
Apellis Pharmaceuticals Inc (NASDAQ: APLS) saw its 5-day average volume 1.82 million, a negative change from its year-to-date volume of 2.22 million. As of the previous 9 days, the stock’s Stochastic %D was 26.18%.
During the past 100 days, Apellis Pharmaceuticals Inc’s (APLS) raw stochastic average was set at 17.31%, which indicates a significant decrease from 51.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.40% in the past 14 days, which was lower than the 53.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.22, while its 200-day Moving Average is $26.45. Nevertheless, the first resistance level for the watch stands at $19.05 in the near term. At $19.48, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.23. If the price goes on to break the first support level at $17.87, it is likely to go to the next support level at $17.12. The third support level lies at $16.69 if the price breaches the second support level.
Apellis Pharmaceuticals Inc (NASDAQ: APLS) Key Stats
The company with the Market Capitalisation of 2.34 billion has total of 125,682K Shares Outstanding. Its annual sales at the moment are 781,370 K in contrast with the sum of -197,880 K annual income. Company’s last quarter sales were recorded 166,800 K and last quarter income was -92,230 K.
